Direct conversion of a general antibody to its catalytic antibody and corresponding applications —Importance and role of Pro95 in CDR-3—

por HIFUMI, Emi, TAGUCHI, Hiroaki, NONAKA, Tamami, UDA, Taizo
Publicado 2023

New technologies to introduce a catalytic function into antibodies: A unique human catalytic antibody light chain showing degradation of β‐amyloid molecule along with the peptidase...

por Hifumi, Emi, Taguchi, Hiroaki, Toorisaka, Eiichi, Uda, Taizo
Publicado 2019

A new catalytic site functioning in antigen cleavage by H34 catalytic antibody light chain

por Hifumi, Emi, Nonaka, Tamami, Taguchi, Hiroaki, Uda, Taizo
Publicado 2022

Obtaining Highly Active Catalytic Antibodies Capable of Enzymatically Cleaving Antigens

por Nonaka, Tamami, Taguchi, Hiroaki, Uda, Taizo, Hifumi, Emi
Publicado 2022

Finding and characterizing a catalytic antibody light chain, H34, capable of degrading the PD-1 molecule

por Hifumi, Emi, Taguchi, Hiroaki, Nonaka, Tamami, Harada, Takunori, Uda, Taizo
Publicado 2020

A new algorithm to convert a normal antibody into the corresponding catalytic antibody

por Hifumi, Emi, Taguchi, Hiroaki, Tsuda, Haruna, Minagawa, Tetsuro, Nonaka, Tamami, Uda, Taizo
Publicado 2020

Biochemical Features of a Catalytic Antibody Light Chain, 22F6, Prepared from Human Lymphocytes

por Hifumi, Emi, Fujimoto, Naoko, Arakawa, Mitsue, Saito, Eri, Matsumoto, Shingo, Kobayashi, Nobuyuki, Uda, Taizo
Publicado 2013